Cardlytics (CDLX) Tops Q4 EPS by 47c ; Offers Guidance

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.00, $0.47 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $74 million versus the consensus estimate of $64.29 million.

GUIDANCE:

Cardlytics sees Q1 2025 revenue of $57-60 million, versus the consensus of $61.25 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Increasing unusual option volume: BLZE ADTN XYL BZFD DOMO IAG ARQQ PRIM USAS IVV ALLT RPD
• US DoE to Jumpstart Nuclear Supply Chain and Accelerate Deployment of Westinghouse AP1000 reactors